Calidi Biotherapeutics, Inc.
CLDI· NYSE
CLDICalidi Biotherapeutics, Inc.
Filed Nov 13, 2025 · 10-Q · 44 days after period end · 0001493152-25-022372
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$5.15M | -$5.05M | -$2.02M | -$5.36M |
| EPS Diluted | -$2.21 | -$7.75 | -$1.41 | -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Calidi Biotherapeutics, Inc. · CIK 1855485 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 13, 2025 · 44 d after period end
